Index RUT P/E - EPS (ttm) -5.53 Insider Own 34.54% Shs Outstand 30.54M Perf Week -2.54%
Market Cap 598.89M Forward P/E - EPS next Y -0.15 Insider Trans -0.14% Shs Float 20.02M Perf Month 6.30%
Income -164.97M PEG - EPS next Q -0.12 Inst Own 53.12% Short Float 3.74% Perf Quarter -11.40%
Sales 277.76M P/S 2.16 EPS this Y 179.37% Inst Trans 5.62% Short Ratio 3.62 Perf Half Y 2.57%
Book/sh 37.28 P/B 0.53 EPS next Y -147.31% ROA -12.73% Short Interest 0.75M Perf Year -31.51%
Cash/sh 6.97 P/C 2.81 EPS next 5Y - ROE -13.76% 52W Range 16.56 - 30.68 Perf YTD -32.27%
Dividend Est. - P/FCF - EPS past 5Y -78.39% ROI -14.39% 52W High -36.18% Beta 1.41
Dividend TTM - Quick Ratio 4.41 Sales past 5Y 258.65% Gross Margin 33.36% 52W Low 18.24% ATR (14) 0.93
Dividend Ex-Date - Current Ratio 4.41 EPS Y/Y TTM -158.64% Oper. Margin -31.92% RSI (14) 50.56 Volatility 4.52% 4.78%
Employees 1184 Debt/Eq 0.01 Sales Y/Y TTM -3.02% Profit Margin -59.39% Recom 2.67 Target Price 26.33
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q -10.28% Payout - Rel Volume 1.06 Prev Close 20.24
Sales Surprise 0.03% EPS Surprise 301.56% Sales Q/Q -15.28% Earnings Nov 08 BMO Avg Volume 206.88K Price 19.58
SMA20 4.16% SMA50 -0.18% SMA200 -7.62% Trades
Volume 219,539 Change -3.26%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Initiated UBS
Neutral
$35
Dec-08-22 Downgrade Piper Sandler
Overweight → Neutral
$65 → $40
Nov-18-22 Initiated Raymond James
Outperform
$45
Aug-25-22 Initiated Credit Suisse
Outperform
$65
Feb-04-22 Resumed Piper Sandler
Overweight
$80
Aug-05-21 Resumed Credit Suisse
Underperform
$55
Jan-08-21 Downgrade Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade BTIG Research
Buy → Neutral
Aug-20-20 Initiated Oppenheimer
Outperform
$75
May-29-20 Initiated BTIG Research
Buy
$20
Nov-05-19 Upgrade Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade Raymond James
Outperform → Mkt Perform
Show Previous Ratings
Dec-09-24 09:55AM
Nov-22-24 12:00PM
Nov-19-24 07:16PM
Nov-09-24 07:31AM
02:05AM
08:15AM
Loading…
Nov-08-24 08:15AM
07:00AM
Nov-05-24 08:00AM
Nov-01-24 08:08AM
Oct-31-24 08:00AM
Oct-17-24 04:05PM
Aug-13-24 12:00PM
09:55AM
Aug-02-24 08:15AM
07:00AM
04:36AM
Loading…
Jul-18-24 04:36AM
Jul-11-24 04:05PM
Jun-10-24 01:00AM
Jun-03-24 08:00AM
May-24-24 08:00AM
May-15-24 04:21AM
(Pharmaceutical Technology)
May-14-24 04:05PM
09:00AM
May-04-24 09:15AM
03:04AM
May-03-24 10:46PM
(Thomson Reuters StreetEvents)
11:53AM
08:34AM
08:15AM
07:00AM
04:05PM
Loading…
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
(Thomson Reuters StreetEvents) -8.14%
07:35AM
07:00AM
Feb-13-24 08:00AM
Feb-09-24 08:31AM
Nov-25-23 09:45AM
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
(Thomson Reuters StreetEvents) +13.24%
04:05PM
08:52AM
08:45AM
07:00AM
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
(Thomson Reuters StreetEvents)
-12.82%
08:15AM
07:00AM
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
(Thomson Reuters StreetEvents)
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
04:06PM
04:05PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Xie Jian President and COO Dec 03 '24 Sale 19.50 1,455 28,372 334,681 Dec 04 04:41 PM Gao Hanlin Chief Scientific Officer Dec 03 '24 Sale 19.50 1,373 26,773 919,469 Dec 04 04:40 PM Gao Hanlin Officer Dec 02 '24 Proposed Sale 19.25 1,397 26,892 Dec 02 07:10 PM Xie Jian Officer Dec 02 '24 Proposed Sale 19.25 1,483 28,548 Dec 02 07:10 PM Hsieh Ming Chief Executive Officer Nov 25 '24 Sale 18.26 2,227 40,663 703,711 Nov 27 05:00 PM Gao Hanlin Chief Scientific Officer Nov 25 '24 Sale 18.26 497 9,075 920,842 Nov 27 05:00 PM Xie Jian President and COO Nov 25 '24 Sale 18.26 689 12,581 336,136 Nov 27 05:00 PM Xie Jian Officer Nov 25 '24 Proposed Sale 18.26 689 12,581 Nov 25 07:04 PM Gao Hanlin Officer Nov 25 '24 Proposed Sale 18.26 497 9,075 Nov 25 07:03 PM Hsieh Ming Owner Nov 25 '24 Proposed Sale 18.26 2,227 40,663 Nov 25 07:03 PM Kim Paul CFO and Treasurer Sep 03 '24 Sale 21.96 1,674 36,763 209,481 Sep 05 04:21 PM Xie Jian President and COO Sep 03 '24 Sale 21.96 1,594 35,006 341,170 Sep 05 04:21 PM Gao Hanlin Chief Scientific Officer Sep 03 '24 Sale 21.96 1,503 33,007 923,057 Sep 05 04:20 PM Xie Jian Officer Sep 03 '24 Proposed Sale 21.96 1,594 35,006 Sep 03 07:37 PM Kim Paul Officer Sep 03 '24 Proposed Sale 21.96 1,674 36,763 Sep 03 07:36 PM Gao Hanlin Chief Scientific Officer Aug 27 '24 Sale 22.83 563 12,855 924,560 Aug 29 06:34 PM Xie Jian President and COO Aug 27 '24 Sale 22.83 715 16,326 342,764 Aug 29 06:33 PM Hsieh Ming Chief Executive Officer Aug 27 '24 Sale 22.83 2,313 52,813 707,275 Aug 29 06:33 PM Kim Paul CFO and Treasurer Aug 27 '24 Sale 22.83 733 16,737 211,155 Aug 29 06:33 PM Hsieh Ming Owner Aug 27 '24 Proposed Sale 22.83 2,313 52,813 Aug 27 08:22 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
